Adjunct Associate Professor of Molecular Pharmaceutics and Drug Delivery
Dr. Su is a Senior Principal Scientist in Pharmaceutical Sciences and Clinical Supplies at Merck & Co., Inc., with over a decade of experience spanning candidate selection, drug delivery, preformulation, formulation, and analytical development for chemical and biological drug products. He earned his Ph.D. in structural biophysics from Iowa State University (2006–2011), followed by postdoctoral training in the Department of Chemistry at MIT (2011–2014). His research focuses on uncovering the molecular mechanisms underlying drug delivery and stability to guide the design of modern therapeutics. Dr. Su has authored over 140 peer-reviewed publications (H-index: 42, as of April 2025) and is a co-inventor on multiple patents for chemical and biological therapeutics, including several on high-concentration aqueous and suspension formulations of pembrolizumab. He currently serves on the Editorial Advisory Boards of Molecular Pharmaceutics, Pharmaceutical Research, and Journal of Pharmaceutical Sciences, and is Editor-in-Chief of AAPS Open (Springer Nature).